Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
AVDL holding history
Avadel Pharmaceuticals PLC in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −16,686−100.0% | Sold out | Holders |
| Q4 2025 | 16,686 | $359.6K | <0.1% | −509,019−96.8% | Reduced | Holders |
| Q3 2025 | 525,705 | $8.03M | <0.1% | +525,705 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −314,343−100.0% | Sold out | Holders |
| Q1 2025 | 314,343 | $2.46M | <0.1% | +314,343 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −195,892−100.0% | Sold out | Holders |
| Q3 2024 | 195,892 | $2.57M | <0.1% | +195,892 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −383,641−100.0% | Sold out | Holders |
| Q1 2024 | 383,641 | $6.48M | <0.1% | +229,056+148.2% | Added | Holders |
| Q4 2023 | 154,585 | $2.18M | <0.1% | −306,218−66.5% | Reduced | Holders |
| Q3 2023 | 460,803 | $4.75M | <0.1% | −148,223−24.3% | Reduced | Holders |
| Q2 2023 | 609,026 | $10.0M | <0.1% | +301,151+97.8% | Added | Holders |
| Q1 2023 | 307,875 | $2.82M | <0.1% | +307,875 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −11,081−100.0% | Sold out | Holders |
| Q2 2022 | 11,081 | $27.0K | <0.1% | −82,046−88.1% | Reduced | Holders |
| Q1 2022 | 93,127 | $636.0K | <0.1% | +93,127 | New | Holders |